Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Evolan Pharma AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 651,155 Less Arrow 637,175 Less Arrow 492,434
Financial expenses 4,565 More Arrow 5,688 Less Arrow 1,178
Earnings before taxes 214,428 Less Arrow 193,127 Less Arrow 156,285
EBITDA 269,172 Less Arrow 268,701 Less Arrow 204,898
Total assets 786,574 Less Arrow 683,409 Less Arrow 577,000
Current assets 665,194 Less Arrow 499,728 Less Arrow 328,876
Current liabilities 137,262 More Arrow 152,879 Less Arrow 142,833
Equity capital 611,063 Less Arrow 490,973 Less Arrow 352,490
- share capital 65 More Arrow 67 Equal arrow 67
Employees (average) 28 More Arrow 29 Less Arrow 27

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 77.7% Less Arrow 71.8% Less Arrow 61.1%
Turnover per employee 23,256 Less Arrow 21,972 Less Arrow 18,238
Profit as a percentage of turnover 32.9% Less Arrow 30.3% More Arrow 31.7%
Return on assets (ROA) 27.8% More Arrow 29.1% Less Arrow 27.3%
Current ratio 484.6% Less Arrow 326.9% Less Arrow 230.3%
Return on equity (ROE) 35.1% More Arrow 39.3% More Arrow 44.3%
Change turnover 35,055 More Arrow 142,206 Less Arrow 45,599
Change turnover % 6% More Arrow 29% Less Arrow 10%
Chg. No. of employees -1 More Arrow 2 Less Arrow 0
Chg. No. of employees % -3% More Arrow 7% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.